AI주식인사이트AI Stock Insight
B

모아라이프플러스

142760KOSDAQ

63.2 / 100

Reference Date: 2026-09-08

Financial Score19.0 / 40
News Sentiment19.2 / 25
Momentum13.0 / 20
Disclosure12.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 69.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Moalifeplus focuses on biopharmaceutical R&D using proprietary technologies (HumaMAX, MucoMAX), alongside consumer businesses such as health functional foods, cosmetics, and pet care products. Its γ-PGA-based functional ingredients are approved by the Korean FDA and the U.S. FDA, enabling global expansion through partnerships with Swiss companies and overseas exports of skincare brands.

Number of Employees

54people

Average Salary

39.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
0.41Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-36.73Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
1.91Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20250.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼21.3% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼12.6% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -13.1% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 5Neutral 0Negative 1Average Sentiment Score 76.7

Detailed Momentum

52-week position1.0Point

Near 52w low (16%, downtrend)

Current 590Won52-week high 1,85052-week low 349
1-month return6.0Point

1m +69.05% (strong rise)

Volume trend6.0Point

Volume surge

Detailed Disclosure

11 totalPositive 1Neutral 10Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-09-02
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-09-02
  • Neutral주식등의대량보유상황보고서(일반)2026-09-02
  • Neutral주권매매거래정지해제 (액면병합 주권 변경상장)2026-08-28
  • Neutral주식등의대량보유상황보고서(약식)2026-08-27